220200-88-4

Basic information

• Product Name: (2R,4R)-4-Methyl-2-trichloro-methyloxazolidin-5-one
• Synonyms: (2R,4R)-4-Methyl-2-trichloro-methyloxazolidin-5-one
• CAS NO: 220200-88-4
• Molecular Formula: C₈H₁₀Cl₃NO₂
• Molecular Weight: 218.46564
• Mol File: 220200-88-4.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 332.5°C at 760 mmHg
• Flash Point: 154.9°C
• Appearance: /
• Density: 1.52g/cm³
• Vapor Pressure: 0.000146mmHg at 25°C
• Refractive Index: 1.564
• CAS DataBase Reference: (2R,4R)-4-Methyl-2-trichloro-methyloxazolidin-5-one(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,4R)-4-Methyl-2-trichloro-methyloxazolidin-5-one(220200-88-4)
• EPA Substance Registry System: (2R,4R)-4-Methyl-2-trichloro-methyloxazolidin-5-one(220200-88-4)

Safety Data

• Hazardous Substances Data: 220200-88-4(Hazardous Substances Data)

Usage

General Description

The chemical compound (2R,4R)-4-Methyl-2-trichloro-methyloxazolidin-5-one is a synthetic organic compound with the molecular formula C5H6Cl3NO2. It is a chiral molecule, meaning it has two non-superimposable mirror image forms (enantiomers). (2R,4R)-4-Methyl-2-trichloro-methyloxazolidin-5-one is used as a reagent in organic synthesis, particularly for the construction of chiral building blocks in pharmaceutical and agrochemical industries. Its structure contains a five-membered oxazolidinone ring with a trichloromethyl group and a methyl group attached to it. The compound's enantiomers can exhibit different properties and reactivity in chemical reactions due to their different spatial arrangements, making them useful for selective synthesis of chiral compounds.

InChI:InChI=1/C8H10Cl3NO2/c1-7-3-2-4-12(7)5(8(9,10)11)14-6(7)13/h5H,2-4H2,1H3/t5-,7+/m1/s1

Upstream product

• 74-83-9 methyl bromide 
• 118916-60-2 (2R,5S)-2-trichloromethyl-1-aza-3-oxabicyclo[3.3.0]octan-4-one 
• 74-88-4 methyl iodide 
• 147-85-3 L-proline 

Downstream Products

• 853400-76-7 glycyl-L-2-methylprolyl-L-glutamic acid 
• 869001-94-5 dibenzyl N-benzyloxycarbonyl-glycyl-L-2-methylprolyl-L-glutamate 
• 847952-40-3 (S)-methyl 1-(2-(((benzyloxy)carbonyl)amino)acetyl)-2-methylpyrrolidine-2-carboxylate 
• 869001-86-5 N-benzyloxycarbonyl-glycyl-L-2-methylproline 
• 123053-48-5 (S)-2-methylpyrrolidine-2-carboxylic acid hydrochloride 
• 42856-71-3 (S)-2-methylpyrrolidine-2-carboxylic acid 
• 220060-08-2 methyl (S)-2-methylpyrrolidine-2-carboxylate monohydrochloride 
• 847952-36-7 (8aS)-8a-methylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione 

Relevant articles and documents

BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME

Embodiments of this invention provide compounds, compositions, methods, and uses for therapeutic diketopiperazines, including cyclic G-2-Allyl Proline and other cyclic Glycyl Proline compounds to treat Pitt Hopkins Syndrome and symptoms thereof, as well a

A Designed Approach to Enantiodivergent Enamine Catalysis

The rational design and implementation of enantiodivergent enamine catalysis is reported. A simple secondary amine catalyst, 2-methyl-l-proline, and its tetrabutylammonium salt function as an enantiodivergent catalyst pair delivering the enantiomers of α-functionalized aldehyde products in excellent enantioselectivities. This novel concept of designed enantiodivergence is applied to the enantioselective α-amination, aldol, and α-aminoxylation/α-hydroxyamination reactions of aldehydes.

NEUROPROTECTIVE BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING AUTISM SPECTRUM DISORDERS AND NEURODEVELOPMENTAL DISORDERS

Embodiments of this invention provide compositions and methods for therapeutic use of diketopiperazines including cyclic G-2-Allyl Proline and other cyclic Glycyl Proline compounds to treat symptoms of Autism Spectrum Disorders and Neurodevelopmental Diso